RIVM analysis: Personalized medicine in medical practice

Implementation in practice and data infrastructures. With personalized medicine, patients are treated on the basis of their unique characteristics, such as hereditary characteristics. This 'tailor-made therapy' is growing rapidly in the medical world as it becomes increasingly clear that many factors together determine whether someone responds well to a medication. Some people have a greater chance of serious side effects of certain medicines because of their hereditary properties. Others are much more sensitive to a drug and therefore need a different dose. Research by the RIVM, however, shows that it is still difficult to translate the knowledge into practical use. For example, it is a challenge to be able to determine which medicines are good for a patient based on individual characteristics. At the same time it must first be demonstrated in a well-founded manner that 'tailor-made therapy' is useful and doctors must be convinced of this. Furthermore, it is often unclear whether testing for a hereditary trait actually improves treatment. These gaps impede application in medical practice, while experiences from this practice provide new insights to improve the use of medicines. You can find the entire report here